SFC Fluidics, Inc.

SFC Fluidics, Inc. is a medical device company whose drug delivery platform can dramatically improve therapy compliance in diabetes and several other important disease markets. SFC has created a disruptive drug delivery platform with an initial target application for insulin delivery to T1D.
With a notably better performing and lower cost drug pump platform, SFC is well-positioned to become a leader in the insulin delivery market. SFC offers improved safety, efficacy, and convenience; therefore, allowing patients to lead active lifestyles without the burden of interference from their diabetes devices.
Although insulin pumps provide markedly better clinical outcomes, they are used by less than 5% of diabetes patients due to the fact current pumps are unwieldy, difficult to use, and expensive. SFC’s patch pump is easier to use, not prone to errors and shortfalls found in existing products, facilitates user compliance, and results in better disease management.